Ross McKenna
Portfolio Manager, Health System Infrastructure
Information Strategy and Architecture
National Health Board Business Unit
Ministry of Health
eHealth Summit: "ICT Use in Irish General Practices: An Intra-Practice Adopti...3GDR
Slides from National eHealth Summit, 30 Sept 2015 at Carton House, Kildare: Jane Bourke, Lecturer in Economics, University College Cork.
#eHealthSummit15
http://www.ehealthsummit.ie
http://mhealthinsight.com/2015/09/25/mhealth-insights-from-the-ehealth-summit/
eHealth Summit: "EU Address: The EU eHealth Strategy: Connecting Member State...3GDR
Slides from National eHealth Summit, 30 Sept 2015 at Carton House, Kildare: Dr Tapani Phia, Head of Unit, eHealth & Health Technology Assessment, European Commission.
#eHealthSummit15
http://www.ehealthsummit.ie
http://mhealthinsight.com/2015/09/25/mhealth-insights-from-the-ehealth-summit/
eHealth Summit: "Case Study: The applied research for connected health (ARCH)...3GDR
Slides from National eHealth Summit, 30 Sept 2015 at Carton House, Kildare: Maria Quinlan, Research Lead Change Work-Package, ARCH.
#eHealthSummit15
http://www.ehealthsummit.ie
http://mhealthinsight.com/2015/09/25/mhealth-insights-from-the-ehealth-summit/
Current regulations regarding eHealth in Europe by Frank Lievens, Executive Secretariat ISfTeH Director, Managing Director Lievens-Lanckman bvba, Belgium
eHealth Summit: "ICT Use in Irish General Practices: An Intra-Practice Adopti...3GDR
Slides from National eHealth Summit, 30 Sept 2015 at Carton House, Kildare: Jane Bourke, Lecturer in Economics, University College Cork.
#eHealthSummit15
http://www.ehealthsummit.ie
http://mhealthinsight.com/2015/09/25/mhealth-insights-from-the-ehealth-summit/
eHealth Summit: "EU Address: The EU eHealth Strategy: Connecting Member State...3GDR
Slides from National eHealth Summit, 30 Sept 2015 at Carton House, Kildare: Dr Tapani Phia, Head of Unit, eHealth & Health Technology Assessment, European Commission.
#eHealthSummit15
http://www.ehealthsummit.ie
http://mhealthinsight.com/2015/09/25/mhealth-insights-from-the-ehealth-summit/
eHealth Summit: "Case Study: The applied research for connected health (ARCH)...3GDR
Slides from National eHealth Summit, 30 Sept 2015 at Carton House, Kildare: Maria Quinlan, Research Lead Change Work-Package, ARCH.
#eHealthSummit15
http://www.ehealthsummit.ie
http://mhealthinsight.com/2015/09/25/mhealth-insights-from-the-ehealth-summit/
Current regulations regarding eHealth in Europe by Frank Lievens, Executive Secretariat ISfTeH Director, Managing Director Lievens-Lanckman bvba, Belgium
This talk was presented on March 4th 2009 at the APAN (Asia Pacific Advanced Networks) meeting in Taiwan. This Healthcare session was organized by Young Sung Lee, Naoki Nakashima and Parvati Dev.
This talk was presented on March 4th 2009 at the APAN (Asia Pacific Advanced Networks) meeting in Taiwan. This Healthcare session was organized by Young Sung Lee, Naoki Nakashima and Parvati Dev.
Jim Warren
National Institute for Health Innovation (NIHI)
The University of Auckland
The presentation was accompanied by this video:
http://www.youtube.com/watch?v=jbvmGqmIxXY
The Role Of Telehealth In Emerging Models Of CareYasnof
Between 2006 and 2036 the proportion of New Zealand’s population aged 65 or over as a proportion of the working-age population is expected to rise from 18 to 40%,” The number of people over Chronic conditions are estimated to account for 70 percent of health funding and 80 percent of all deaths in New Zealand and health workforce numbers per person are expected to decrease over next 20 years. This presentation explores the potential of Telehealth to address these challenges
Health Care Panel presented to the Minnesota Ultra High-Speed Broadband Task ...Ann Treacy
Presentations from the Health Care Panel presented to the Minnesota Ultra High-Speed Broadband Task Force on March 20, 2009. Presenters include: Stuart Speedie, Professor, U of M Medical School, Health Informatics, Karen Welle, Asst Director, MN Dept of Health, Office of Rural Health & Primary Care, Maureen Ideker, Rice Memorial Hospital, Chief Nursing Officer, Steve Mulder, Hutchinson Area Health Care Director of Quality and Clinical Services, Joe Schindler, MN Hospital Association, Mark Schmidt, SISU Chief Information Officer, Dr Eduard Michel, Emergency Physician.
20191203 DOE Data Driven Healthcare- Expert EventDayOne
DayOne Experts - Data-driven healthcare – are we ready?
Data is transforming healthcare. Health data from multiple sources such as electronic health records, genomic testing, imaging and digital tools, combined with advanced analytics can be used to deliver more personalised care, improve outcomes, empower patients and make healthcare more sustainable and efficient. But is the industry ready for these new approaches? What is needed on the policy level and in the regulatory field to enable a new era of data driven health solutions? How will their business models look like?
This is what we discussed at this DayOne Expert Event, which was proudly presented in close collaboration with the Embassy of the Netherlands, fostering the exchange between two world leading healthcare innovation ecosystems.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
The Role of Telehealth in Emerging Models of Care
1. The Role of Telehealth in Emerging Models of Care - moving from information exchange to person-centred, technology-enabled care Ross McKenna Portfolio Manager, Health System Infrastructure Information Strategy and Architecture National Health Board Business Unit Ministry of Health HINZ Telehealth Seminar 2009
4. Recommended definitions Telehealth Provision of heath care and information at a distance using Information and Communications Technology Telemedicine Application of clinical medicine at at a distance using Information and Communications Technology Telecare Provision of health care and support using Information and Communication Technology to empower people to remain independent in their own homes
5.
6. Telehealth – enabling health system change Workforce effectiveness Personalised care Preventative Care Resource effectiveness Connected Health – networks, architecture, standards Integrated Family Health Centres TELEMEDICINE TELECARE Chronic conditions Education Self management Family/whänau support Remote consultations Video conferencing Peer review/support Shared systems Home Based
7.
8. Models of care – moving from recipient to participant (technology enabled) MODEL R(ecipient) MODEL P(articipant) CSIP, UK Department of Health “Supporting Long-term Conditions and Disease Management through Telecare and Telehealth: evidence and challenges, January 2008 Preparing for Success: Readiness Models for Rural Telehealth Jnl Postgrad Med December 2005 Journal of Participatory Medicine Provider delivered at the hospital Illness and treatment Site of care focused Episodic care Workforce constrained Solitary decision making – referral based Efficiency Decentralised, independent Person & whänau involved in the community/home – provider as colleague/advisor Wellness and informed/responsible/participating/empowered Continuum of care – home and mobility Disease prevention and management Demand managed Patient involved, collaborative, evidence based decisions – co-diagnosis, co-care Efficiency and Effectiveness Coordinated, specialised care
9.
10.
11.
12.
13.
14.
15. QUESTIONS? Web references Presentations from the supported self management seminars held in June 2009: http://www.moh.govt.nz/moh.nsf/indexmh/longtermconditions-masterclasses 2007 Synergia Self Care Literature Review http://www.synergia.co.nz/assets/file/Role%20of%20information%20in%20self-care%20July%202007.pdf Link to Genetic and Bioinformatics resources: http://www.ornl.gov/sci/techresources/Human_Genome/posters/chromosome/tools.shtml NZ Government Broadband Initiatives – MED site http://www.med.govt.nz/templates/StandardSummary____40551.aspx
Editor's Notes
Paediatrics and Mental Health
Good morning everyone. I would like to help set the scene for the presentations to follow by offering some suggested common terminology, talking about the New Zealand context for Telehealth and outlining the potential opportunities, providing some information on current relevant initiatives, discussing a couple of emerging Telehealth care models. And summarising some actions going forward.
Telehealth, Telecare and Telemedicine are terms that are often used interchangeably,. Given the wide range of definitions used to describe technology enabled health care I though it would be useful to simplify the debate and this presentation by offering some common definitions. While there are a wide range of definitions, some common themes are apparent across UK US and Australian usage. These align reasonably well to the definitions for Health, medicine and care. The term Telehealth is most often used in the context of an overarching term for all forms of technology enabled health care provided at a distance. Telemedicine involves the application and practise of medicine, generally between health professionals and for diagnoses and referral – subsets are specific medical disciplines such as Teleradiology and teledermatology. Areas that are becoming increasingly accepted as part of mainstream care models – evidenced by decreasing use of the “tele” prefix in areas such as paediatrics. Telecare now has wide usage and formal acceptance in the UK as the provision of care to end users in the home setting and is evolving to mean services that allow aging and chronically ill people to stay out of institutional care. The spin off benefit is greater independence and it is this area where the benefits of person cantered Telehealth – where people are participants rather than simply receivers of care – is increasingly recognised as providing the potential for major improvements in health system productivity. both Telecare and Telehealth offer significant potential to address many of the current pressures on the health system and I’d like to spend a few moments discussing these 2 areas today.
It is no surprise to anyone here that we are about to experience a significant increase in demand for health care. “ Between 2006 and 2036 the proportion of New Zealand’s population aged 65 or over as a proportion of the working-age population is expected to rise from 18 to 40%,” The number of people over Chronic conditions are estimated to account for 70 percent of health funding and 80 percent of all deaths in New Zealand and health workforce numbers per person are expected to decrease over next 20 years Not a system. Department of labour p rojections show that the number of paid caregivers required in New Zealand will rise almost three-fold from 17,900 in 2006 to 48,000 in 2036. There is likely to be a significant time lag between the economy returning to growth and fuller employment and the Government's deficit being reduced by increased tax revenues. In other words, next year's budget will be even tighter. The Government is borrowing $250m a week for the next 4 years. So we have to get maximum value out of every health dollar. We also have a health environment where there is an increasing range of medicines and interventions available - they all cost money so how do we decide where to focus any technology investment.
Evidence from overseas experience suggests that Telehealth offers scope to support long term condition self-management and to provide scope to better use health resources. In terms of telemedicine this has potential to provide more efficient and effective treatment and diagnostic services Keeping people out of hospital/aged care by allowing them to be treated in primary care and stay at home Enabling more effective use of increasingly stretched resources though education, support and removing the barrier of distance. Telecare proves the capability for people to stay out of hospital by being in a position to confidently care for themselves without leaving the home. The Scottish Government has been running a Telecare Development Programme that has shown some success in these areas and they believe these benefits can be significantly improved by moving to a mainstream “third generation” Telecare service. However, evidence also shows that this is very difficult to achieve if you are employing models of care where the person is viewed as a recipient rather that a participate in the care process. Moving to this kind of person-centred, co production health care model is no small thing and will require new ways of working and interaction for all involved. However, there are a couple of initiatives in terms of the establishment of IFHCs and Connected health that can support this transition to mainstream “3 rd generation” services. EU 2009 has reinforced requirement for Interoperability Standards Mandate M403 on adoption of standards to support Health record sharing as an enabler for a more patient centred health system/s Connected Health is a programme of work focussed on enabling safe sharing of health information and will support the system interoperability needed for Telehealth to gain wide adoption.
First Generation medic alert type services – as in common use in NZ today – react to user generated need Second – Kent, England example were 12 types of passive devise were used in 3 trials beginning in 2004 – movement sensors, call buttons, smoke flood and fall detectors – bed, chair and exit (house) sensors At the end of 2006, 320 people using Telecare services through the pilots – main measured benefits were psychological – helping them be confident they could safely remain in the home. 3 rd Generation In the Netherlands, - with 2.4 million people over 65! The Koala project provides video phones to 600 users with clinic conditions, diabetes and heart conditions and use TV remotes to set up calls to remote nursing centers who can see the patients care record and remote devise monitoring details
As Telecare has evolved from simply reactive response services there is increasing research and support for care models that enable “participatory” medicine – or “patient centred collaborative care, This focuses not on treating people that are ill, but fostering and supporting people who could be healthier if it were simpler to care for themselves. Telecare can assist in helping people with understanding there own condition through monitoring and alerts as well as medication management and guiding them on treatments and prevention. In the pacific and New Zealand context this approach also fits well with the concepts of family well being in providing individuals with support for self care.
The Better, Sooner, More Convenient, primary Care plan also provides an opportunity for programmes that move care from the hospital to primary care and, potentially, into the home. The EOI process will, based on the successful submissions in the first wave create more than 32 new community based IFHCs and whänau ora centres that can provide the capability to run home based Telecare models. They are intended to be technology hubs and if the business cases can show benefits in terms of reduced load on hospital services they could result in a significant growth in the number of telecare models in place. Person centred services as part of integrated preventative and chronic care management programmes that result in quantifiable benefits – e.g. reduced admissions and bed days Some potential use cases Health Education, Rehabilitation Intermediate care Hospice/palliative care Home safety and activity detection – e.g. falls Assistive technologies, Self care Monitoring, health condition and device performance Note – Evidence that increasing sophistication and cost does not always equate to better health outcomes Expected benefits of UFB for Health are in deployment of: Video based services Greater sharing of electronic health information – improved access and workflow Integrated Family Health Centres Diagnostic Imaging Telecare – home based Shared systems and applications
In August 09 Cabinet agreed that: to take advantage of the governments $1.5 Billion UFB investments for Health, MoH will work on behalf on clinicians and consumers to help ensure that: the priorities for the health sector are understood and that services are, as much as possible, able to be implemented in areas of high need “ use of Faster Broadband and the potential for technology enabled improvements in healthcare are a part of new Integrated Family Health Centre proposals ” While this will not directly enable Telehealth initiatives, it should remove barriers in areas where lack of any level of broadband is limiting the deployment of Telemedicine or Telecare. Also, the general wider availability of broadband over the years of the deployment will support more availability of services such as those based on video.
Given all this potential for Telehealth, I’d like to paint a bit of a picture of a possible future based around a few models of care that are emerging due to the massive changes in availability and accessibility of health care information, technology development and increasing ability to analyse and synthesise data.
Health Social Networking sites are providing people with the opportunity to be supported in the self care efforts – through access to health information, easy access to medical advise and support, a community of caring supporters and even the opportunity to participate in clinical trials. As an example, this site now has the largest available set of information on a particular health condition. However, there are still significant potential issues in terms of ownership and privacy of information.
The range of test information available today also has potential to support self care and home based telemedicine. Here is an example of a set of tests ordered from direct labs. Entelos partners with pharmaceutical and biotechnology organizations to develop new treatments for disease and reduce the time and cost needed to develop them. Entelos develops dynamic large-scale computer models of human disease. integrating data (e.g., genomic, proteomic, physiologic, environmental) in the context of a disease or therapeutic area, focusing on understanding and determining clinical responses to potential treatment Consider how these models plus personal health tracking devices might start to converge and enable person centre, participatory Telecare based models to evolve that can keep people healthier and out of hospital.
I hope you agree that there is opportunity to make use of Telehealth to drive positive health system change. The challenge will be to do this in such a way that it results in real quantifiable benefits in terms of keeping people independent and health. The more significant opportunity seems to be in terms of enabling them to practise supported self care in the home. We do have some changes that should support these types in approaches in terms of changes to primary care the Connected Health programme and wider broadband availability over time .Capitalise on existing Telehealth initiatives (E.g ASSET and West Coast) Assess the need for central policy on; applicability, assessment and safety aspects of Telecare Move to a shared health record approach that will allow for integration and interoperability with personal health records. Thank you for your time and any questions?